CL2010001230A1 -
Method for inhibiting melanogenesis comprising administering a steroidal compound; pharmaceutical composition; topical formulation, useful in the treatment of a disease or condition that involves melanogenesis.
- Google Patents
Method for inhibiting melanogenesis comprising administering a steroidal compound; pharmaceutical composition; topical formulation, useful in the treatment of a disease or condition that involves melanogenesis.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New YorkfiledCriticalUniv New York
Priority to CL2010001230ApriorityCriticalpatent/CL2010001230A1/en
Publication of CL2010001230A1publicationCriticalpatent/CL2010001230A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Método para inhibir la melanogénesis que comprende administrar un compuesto esteroidal; composición farmacéutica; formulación tópica, útil en el tratamiento de una enfermedad o condición que involucra melanogénesis.Method for inhibiting melanogenesis comprising administering a steroidal compound; pharmaceutical composition; Topical formulation, useful in the treatment of a disease or condition that involves melanogenesis.
CL2010001230A2010-11-102010-11-10
Method for inhibiting melanogenesis comprising administering a steroidal compound; pharmaceutical composition; topical formulation, useful in the treatment of a disease or condition that involves melanogenesis.
CL2010001230A1
(en)
Method for inhibiting melanogenesis comprising administering a steroidal compound; pharmaceutical composition; topical formulation, useful in the treatment of a disease or condition that involves melanogenesis.
Method for inhibiting melanogenesis comprising administering a steroidal compound; pharmaceutical composition; topical formulation, useful in the treatment of a disease or condition that involves melanogenesis.
Method for inhibiting melanogenesis comprising administering a steroidal compound; pharmaceutical composition; topical formulation, useful in the treatment of a disease or condition that involves melanogenesis.
Pharmaceutical composition for preventing or treating diabetes comprising a long-acting insulin conjugate and a long-acting insulinotropic peptide conjugate.
compound, pharmaceutically acceptable salt of a compound, pharmaceutical composition, method for treating or preventing disorders, and use of a compound or salt
Use of a pegylated variant of igf-1 to treat, prevent a neuromuscular disorder; method for the treatment, prevention and / or delay of a neuromuscular disorder; composition comprising the modified igf-1 variant
Method for the treatment, prevention or reduction of the severity of a non-neoplasic skin condition or disorder that comprises administering a retinoid-derived compound; Dermal composition comprising retinoid derivatives.